Glial Interfaces: Advanced Materials and Devices to Uncover the Role of Astroglial Cells in Brain Function and Dysfunction

Abstract

Research over the past four decades has highlighted the importance of certain brain cells, called glial cells, and has moved the neurocentric vision of structure, function, and pathology of the nervous system toward a more holistic perspective. In this view, the demand for technologies that are able to target and both selectively monitor and control glial cells is emerging as a challenge across neuroscience, engineering, chemistry, and material science. Frequently neglected or marginally considered as a barrier to be overcome between neural implants and neuronal targets, glial cells, and in particular astrocytes, are increasingly considered as active players in determining the outcomes of device implantation. This review provides a concise overview not only of the previously established but also of the emerging physiological and pathological roles of astrocytes. It also critically discusses the most recent advances in biomaterial interfaces and devices that interact with glial cells and thus have enabled scientists to reach unprecedented insights into the role of astroglial cells in brain function and dysfunction. This work proposes glial interfaces and glial engineering as multidisciplinary fields that have the potential to enable significant advancement of knowledge surrounding cognitive function and acute and chronic neuropathologies.

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 26, 2020
Source ID
10.1002/adhm.202001268

Entities

People

  • Annalisa Convertino
  • Emanuela Saracino
  • Luca Maiolo
  • Luigi Ambrosio
  • Manuela Melucci
  • Michele Muccini
  • Roberto Zamboni
  • Valentina Benfenati
  • Vincenzo Guarino

Organizations

  • Air Force Office of Scientific Research
  • Consiglio Nazionale delle Ricerche

Tags

Readers

  • Immunology and Pathology
  • Systems Analysis and Design
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.